Literature DB >> 1911111

Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children.

E Ingulli1, A Tejani.   

Abstract

The North American Pediatric Registry reports that from 1987 to 1989 blacks and Hispanic children accounted for 23% of all renal transplants performed but 38% of those performed for focal segmental glomerulosclerosis (FSGS). From these data, we infer that blacks and Hispanics form a disproportionate number of FSGS patients who progress to end-stage renal disease (ESRD) compared with white children. To explore this hypothesis we assessed our single-center experience of FSGS comparing black and Hispanic with white children. Of 177 black and Hispanic children followed in our clinic for idiopathic nephrotic syndrome (NS) between 1974 and 1989, 57 were diagnosed as having FSGS (group I). The mean age at onset of NS of these group I patients was 7.3 +/- 4.6 years and the mean duration of follow-up was 8.25 +/- 4.3 years. During the same period, 13 of 65 white patients (group II) with idiopathic NS were found to have FSGS. Their mean age (7.8 +/- 4.8 years) and duration of follow-up (8.8 +/- 4.8 years) were similar. Therapeutic modalities in the two groups were also similar. Of group I patients, 78% (42/54) reached ESRD compared with 33% (4/12) of group II patients (P less than 0.01). Life table analysis showed that 50% of black and Hispanic children will reach ESRD within 3 years of FSGS.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911111     DOI: 10.1007/bf01453661

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  PERSISTENT NEPHROTIC SYNDROME: A RENAL BIOPSY STUDY.

Authors:  V J MCGOVERN
Journal:  Australas Ann Med       Date:  1964-11

2.  Prognosis in the nephrotic syndrome. A study based on renal biopsy findings.

Authors:  J S Horvath; J R Johnson; D G Horvath
Journal:  Med J Aust       Date:  1971-07-31       Impact factor: 7.738

3.  Morphological transition in minimal change nephrotic syndrome.

Authors:  A Tejani
Journal:  Nephron       Date:  1985       Impact factor: 2.847

4.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

Review 5.  The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases.

Authors:  R Habib; C Kleinknecht
Journal:  Pathol Annu       Date:  1971

6.  The 1989 report of the North American Pediatric Renal Transplant Cooperative Study.

Authors:  S R Alexander; G S Arbus; K M Butt; S Conley; R N Fine; I Greifer; A B Gruskin; W E Harmon; P T McEnery; T E Nevins
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

7.  Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

Authors:  J Churg; R Habib; R H White
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

8.  Absence of 'true' minimal change nephrotic syndrome in African children in South Africa.

Authors:  M Adhikari; H M Coovadia; V Chrystal; L Morel-Maroger
Journal:  J Trop Med Hyg       Date:  1983-12

9.  Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1982-10       Impact factor: 4.406

10.  Primary nephrosis in childhood associated with focal glomerular sclerosis: is long-term prognosis that severe?

Authors:  J G Mongeau; L Corneille; P Robitaille; S O'Regan; M Pelletier
Journal:  Kidney Int       Date:  1981-12       Impact factor: 10.612

View more
  41 in total

Review 1.  The clinical trial imperative.

Authors:  Debbie Gipson; Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

2.  Idiopathic collapsing focal segmental glomerulosclerosis in pediatric patients.

Authors:  Ahmed M El-Refaey; Gaurav Kapur; Amrish Jain; Guillermo Hidalgo; Abubakr Imam; Rudolph P Valentini; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2006-12-06       Impact factor: 3.714

3.  Iothalamate versus estimated GFR in a Hispanic-dominant pediatric renal transplant population.

Authors:  Karen E Papez; Gina-Marie Barletta; Stephanie Hsieh; Mark Joseph; Bruce Z Morgenstern
Journal:  Pediatr Nephrol       Date:  2013-12       Impact factor: 3.714

4.  Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome.

Authors:  Michelle N Rheault; Chang-Ching Wei; David S Hains; Wei Wang; Bryce A Kerlin; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2013-09-14       Impact factor: 3.714

5.  Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study.

Authors:  Natalia Konstantelos; Tonny Banh; Viral Patel; Jovanka Vasilevska-Ristovska; Karlota Borges; Neesha Hussain-Shamsy; Damien Noone; Diane Hebert; Seetha Radhakrishnan; Christoph P B Licht; Valerie Langlois; Rachel J Pearl; Rulan S Parekh
Journal:  Pediatr Nephrol       Date:  2019-04-11       Impact factor: 3.714

6.  Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis.

Authors:  Marcelo M Abrantes; Luis Sergio B Cardoso; Eleonora M Lima; José M Penido Silva; José S Diniz; Eduardo A Bambirra; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2006-05-30       Impact factor: 3.714

7.  Pathological profile of biopsied Egyptian children with primary nephrotic syndrome: 15-year single center experience.

Authors:  Ashraf Bakr; Riham Eid; Amr Sarhan; Ayman Hammad; Ahmed Mahmoud El-Refaey; Atef El-Mougy; Mohammed Magdy Zedan; Fatma Moustafa; Ashraf Abdelrahman
Journal:  J Nephrol       Date:  2014-01-16       Impact factor: 3.902

8.  Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome.

Authors:  Mukta Mantan; Chenni S Sriram; Pankaj Hari; Amit Dinda; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2008-06-20       Impact factor: 3.714

9.  Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.

Authors:  Tonny H M Banh; Neesha Hussain-Shamsy; Viral Patel; Jovanka Vasilevska-Ristovska; Karlota Borges; Cathryn Sibbald; Deborah Lipszyc; Josefina Brooke; Denis Geary; Valerie Langlois; Michele Reddon; Rachel Pearl; Leo Levin; Monica Piekut; Christoph P B Licht; Seetha Radhakrishnan; Kimberly Aitken-Menezes; Elizabeth Harvey; Diane Hebert; Tino D Piscione; Rulan S Parekh
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 8.237

10.  Impact of tuberculosis in children with idiopathic nephrotic syndrome.

Authors:  U Kala; L S Milner; D Jacobs; P D Thomson
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.